Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

OBJECTIVE: To evaluate the psychosocial impact of participation in a population-based prostate-specific antigen (PSA) testing programme, akin to screening, and to explore the relationship between urinary symptoms reported before PSA testing and the response to the subsequent PSA result. PATIENTS AN...

Полное описание

Библиографические подробности
Главные авторы:	Brindle, L, Oliver, SE, Dedman, D, Donovan, J, Neal, D, Hamdy, F, Lane, J, Peters, T
Формат:	Journal article
Язык:	English
Опубликовано:	2006

Схожие документы

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
по: Moore, A, и др.
Опубликовано: (2009)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
по: Avery, K, и др.
Опубликовано: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
по: Avery, K, и др.
Опубликовано: (2012)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
по: Down, L, и др.
Опубликовано: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
по: Down, L, и др.
Опубликовано: (2011)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
по: J. Donovan, и др.
Опубликовано: (2003-01-01)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
по: Hamdy, F, и др.
Опубликовано: (2006)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
по: Young, GJ, и др.
Опубликовано: (2017)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
по: Hamdy, F, и др.
Опубликовано: (2006)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
по: Macefield, R, и др.
Опубликовано: (2009)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
по: Hamdy, F, и др.
Опубликовано: (2006)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
по: Avery, K, и др.
Опубликовано: (2008)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
по: Oliver, SE, и др.
Опубликовано: (2004)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
по: Rosario, D, и др.
Опубликовано: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
по: Rosario, D, и др.
Опубликовано: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
по: Rosario, D, и др.
Опубликовано: (2012)

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
по: Williams, N, и др.
Опубликовано: (2011)

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
по: Williams, N, и др.
Опубликовано: (2011)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
по: Neal, D, и др.
Опубликовано: (2006)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
по: Rosario, D, и др.
Опубликовано: (2008)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
по: Simpkin, A, и др.
Опубликовано: (2013)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
по: Collin, S, и др.
Опубликовано: (2009)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
по: Burton, A, и др.
Опубликовано: (2011)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
по: Harrison, S, и др.
Опубликовано: (2020)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
по: Vickers, A, и др.
Опубликовано: (2010)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
по: Collin, S, и др.
Опубликовано: (2009)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
по: Lane, J, и др.
Опубликовано: (2010)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
по: Collin, S, и др.
Опубликовано: (2010)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
по: Turner, E, и др.
Опубликовано: (2011)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
по: Tilling, K, и др.
Опубликовано: (2010)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
по: Oliver, SE, и др.
Опубликовано: (2004)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
по: Harrison, S, и др.
Опубликовано: (2016)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
по: Lane, J, и др.
Опубликовано: (2007)

Measurement of the insulin-like growth factor (IGF)-axis does not enhance the specificity of PSA-based prostate cancer screening.
по: Oliver, SE, и др.
Опубликовано: (2002)

Screening for prostate cancer. The case against.
по: Donovan, J, и др.
Опубликовано: (2005)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
по: Avery, K, и др.
Опубликовано: (2007)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
по: Donovan, J, и др.
Опубликовано: (2003)

10-year outcomes in localized prostate cancer.
по: Hamdy, F, и др.
Опубликовано: (2017)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
по: Lane, J, и др.
Опубликовано: (2009)

Prostate cancer: screening approaches.
по: Donovan, J, и др.
Опубликовано: (2005)